{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-25-000152","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.610627+00:00","generated_at":"2026-05-17T17:11:33.693553+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PacBio Q2 revenue up 10.5% YoY to $39.8M; GAAP net loss narrows to $41.9M","bullets":["GAAP net loss per share of $0.14 improved from $0.64 YoY; non-GAAP EPS -$0.13 vs -$0.20.","Consumable revenue $18.9M (+11% YoY); service & other revenue $6.7M (+56% YoY).","Shipped 15 Revio and 38 Vega systems; Revio annualized pull-through ~$219K/system.","Cash, equivalents, and investments $314.7M, down from $509.8M a year earlier.","Non-GAAP operating expenses cut to $58.1M from $71.0M YoY; CEO cites disciplined cost management."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-25-000152","json":"https://secwatch.observer/filing/0001299130-25-000152.json","markdown":"https://secwatch.observer/filing/0001299130-25-000152.md","text":"https://secwatch.observer/filing/0001299130-25-000152.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000152/0001299130-25-000152-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000152/pacb-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:11:33.693553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}